The European Liver Patients’ Association (ELPA) participated in the ARTEMIS General Assembly on January 22 and 23, 2026, bringing together partners from across Europe to review progress, exchange expertise, and shape the next phase of collaborative work. The General Assembly provided an important opportunity to reflect on achievements to date, align on strategic priorities, and

On February 3, 2026, on the eve of World Cancer Day, Cancer Patients Europe (CPE) hosted the high-level policy event “Nutrition in Cancer Care: Closing the Gap Between Awareness and Action” at the European Parliament in Brussels, marking the launch of its new European White Paper on nutritional support in cancer care. The event brought

On 24 February 2026, to mark World Rare Disease Day (February 28), ELPA hosted a high-level policy event at the European Parliament in Brussels, bringing together policymakers, clinicians, regulators, and patient advocates to address the urgent challenges posed by rare liver diseases. The meeting highlighted the persistent gaps in prevention, early diagnosis, and access to

ELPA collaborated to draft a new article published in Psychology, Health & Medicine (2026), which highlights the significant impact of stigma on the mental health and quality of life of people living with liver diseases, including hepatitis, cirrhosis, MASLD, and MASH. The study shows that stigma—often driven by misconceptions linking liver disease to personal behaviour